Get started
Gilead Sciences, Inc. 4.8% 15-NOV-2029Gilead Sciences, Inc. 4.8% 15-NOV-2029Gilead Sciences, Inc. 4.8% 15-NOV-2029

Gilead Sciences, Inc. 4.8% 15-NOV-2029

No trades
See on Supercharts
Overview
Analysis

GILD5939388 chart


Full chart

Key terms


Outstanding amount
—
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
4.80% (Fixed)
Coupon frequency
—
Yield to maturity
4.80%
Maturity date
Nov 15, 2029
Term to maturity
4 years

About Gilead Sciences, Inc. 4.8% 15-NOV-2029


Issuer
Gilead Sciences, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
gilead.com
Issue date
Nov 20, 2024
FIGI
BBG01QSG5HT1
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.